A Phase 3, Multicenter, Multinational, Randomized, Open-

Project: Research project

Project Details

Description

A Phase 3, Multicenter, Multinational, Randomized,Open-Label,Parallel-Arm Study of Avelumab(MSB0010718C) Plus Best Supportive
StatusActive
Effective start/end date4/21/1612/31/21

Funding

  • PFIZER, INC.